NAV
₹351.2809
as of 31 Jul 2026
Expense Ratio
—
see scheme documents
Lumpsum returns (CAGR)
- 1Y
- +5.29%
- 3Y
- +13.41%
- 5Y
- +13.36%
- Since Inception
- +18.16%
SIP returns (XIRR)
- 1Y
- +9.48%
- 3Y
- +9.28%
- 5Y
- +13.06%
- Since Inception
- +14.92%
Performance Comparison
Sectoral allocation
as of 31 May 2026- Pharmaceuticals & Biotechnology9.63%
- Banks8.91%
- Auto Components8.11%
- Industrial Products7.97%
- Consumer Durables7.45%
- Finance5.65%
- Capital Markets5.51%
- IT - Software5.40%
- Electrical Equipment4.62%
- Retailing3.51%
- Chemicals & Petrochemicals3.34%
- Insurance3.10%
Each sector links to the mutual funds most exposed to it.
Thinking about UTI Mid Cap Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Fund Details
Available transactions
Portfolio holdings
portfolio shared with UTI Mid Cap Fund - Regular Plan - IDCW
- 1Polycab India Ltd2.40%
- 2Pb Fintech Ltd2.37%
- 3Tube Investments Of India Ltd2.33%
- 4Max Financial Services Ltd.2.19%
- 5Suzlon Energy Ltd.2.11%
- 6Coforge Ltd2.04%
- 7Bse Ltd2.01%
- 8Phoenix Mills Ltd1.94%
- 9Federal Bank Ltd.1.87%
- 10Ajanta Pharma Ltd.1.85%
Investment Objective
UTI Mid Cap Fund · Direct · Growth seeks to generate long-term capital appreciation by investing in mid-cap companies — ranked 101st to 250th by market capitalisation. These companies offer a balance of growth potential and relative stability, making them suitable for investors with moderate to high risk appetite.
About This Fund
UTI Mid Cap Fund · Direct · Growth is a Mid Cap mutual fund offered by UTI Mutual Fund. The fund has been operational for over 13 years.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations